Abstract
Early detection of hepatocellular carcinoma (HCC) is clinically important because advanced HCC limits treatment modalities for the cancer. We have previously reported that serum levels of MAGE‐4 protein are strongly associated with the development of HCC. The present study was designed to determine whether elevated serum MAGE‐4 protein levels can predict hepatocellular carcinogenesis in patients with liver cirrhosis before clinical diagnosis. Among 62 cirrhotic patients, 28 patients were diagnosed with HCC during the follow‐up period. The levels of MAGE‐4 protein and a‐fetoprotein (AFP) were significantly elevated in cirrhotic patients with HCC. Univariate and multivariate analyses suggest that elevated serum MAGE‐4 protein is more significant than AFP. Importantly, retrospective analysis of prefrozen sera of cirrhotic patients revealed a transient or continuous elevation of serum MAGE‐4 protein levels in 14 of 28 cirrhotic patients with HCC (50%) before clinical diagnosis. In contrast, elevated serum MAGE‐4 protein levels were observed in 3 of 33 cirrhotic patients without HCC (9%), and in 2 of 34 hepatitic patients (6%). These results indicate that elevated serum MAGE‐4 protein levels can be a predictive marker of hepatocellular carcinogenesis in cirrhotic patients, thereby enabling us to treat patients at an earlier stage.
Keywords: MAGE‐4, hepatocellular carcinoma, liver cirrhosis, marker
Full Text
The Full Text of this article is available as a PDF (86.7 KB).
REFERENCES
- 1.Saito , I. , Miyamura , T. , Ohbayashi , A. , Harada , H. , Katayama , T. , Kikuchi , S. , Watanabe , Y. , Koi , S. , Onji , M. and Ohta , Y.Hepatitis C virus infection is associated with the development of hepatocellular carcinoma . Proc. Natl. Acad. Sci. USA , 87 , 6547 – 6549 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Nishioka , K. , Watanabe , J. , Furuta , S. , Tanaka , E. , Lino , S. , Suzuki , H. , Tsuji , T. , Yano , M. , Kuo , G. and Choo , Q. L.A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan . Cancer , 67 , 429 – 433 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 3.Tsukuma , H. , Hiyama , T. , Tanaka , S. , Nakao , M. , Yabuuchi , T. , Kitamura , T. , Nakanishi , K. , Fujimotoo , I. , Inoue , A. and Yamazaki , H.Risk factors for hepatocellular carcinoma among patients with chronic liver disease . N. Engl. J. Med. , 328 , 1797 – 1801 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 4.Oka , H. , Tamori , A. , Kuroki , T. , Kobayashi , K. and Yamamoto , S.Prospective study of alpha‐fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma . Hepatology , 19 , 61 – 66 ( 1994. ). [PubMed] [Google Scholar]
- 5.Kuromatsu , R. , Tanaka , M. and Tanikawa , K.Serum alpha‐fetoprotein and Lens culinaris agglutinin‐reactive fraction of alpha‐fetoprotein in patients with hepatocellular carcinoma . Liver , 13 , 177 – 182 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 6.Tarao , K. , Takemiya , S. , Tamai , S. , Sugimasa , Y. , Ohkawa , S. , Akaike , M. , Tanabe , H. , Shimizu , A. , Yoshida , M. and Kakita , A.Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotrans‐ferase levels in the hepatectomized patients with hepatitis C virus‐associated cirrhosis and HCC . Cancer , 79 , 688 – 694 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 7.Tarao , K. , Rino , Y. , Ohkawa , S. , Shimizu , A. , Tamai , S. , Miyakawa , K. , Aoki , H. , Imada , T. , Shindo , K. , Okamoto , N. and Totsuka , S.Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatic C virus‐associated cirrhosis . Cancer , 86 , 589 – 595 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 8.van der Bruggen , P. , Traversari , C. , Chomez , P. , Lurquin , C. , De Plaen , E. , Van der Eynde , B. , Knuth , A. and Boon , T.A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma . Science , 254 , 1643 – 1647 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 9.de Plaen , E. , Arden , K. , Traversari , C. , Gaforio , J. J. , Szikora , J. P. , De Smet , C. , Brasseur , F. , van der Bruggen , P. , Lethe , B. , Hurquin , C. , Brasseur , R. , Chomez , P. , De Backer , O. , Cavenee , W. and Boon , T.Structure, chromosomal localization, and expression of 12 genes of the MAGE family . Immunogenetics , 49 , 360 – 369 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 10.Weynants , P. , Lethe , B. , Brasseur , F. , Marchand , M. and Boon , T.Expression of MAGE genes by non‐small‐cell lung carcinomas . Int. J. Cancer , 56 , 826 – 829 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 11.Shichijo , S. , Tsunosue , R. , Kubo , K. , Kuramoto , T. , Tanaka , Y. , Kayashi , A. and Itoh , K.Establishment of an enzyme‐linked immunosorbent assay (ELISA) for measuring cellular MAGE‐4 protein on human cancers . J. Immunol Methods , 186 , 137 – 149 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 12.Takahashi , K. , Shichijo , S. , Noguchi , M. , Hirohata , M. and Itoh , K.Identification of MAGE‐1 and MAGE‐5 proteins in spermatogonia and primary spermatocytes of testis . Can- cer Res. , 55 , 3478 – 3482 ( 1995. ). [PubMed] [Google Scholar]
- 13.Toh , Y. , Yamana , H. , Shichijo , S. , Fujita , H. , Tou , U. , Sakaguchi , M. , Kakegawa , T. and Itoh , K.Expression of MAGE‐1 gene by esophageal carcinomas . Jpn. J. Cancer Res. , 86 , 714 – 717 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Iwamoto , O. , Nagao , Y. , Shichijo , S. , Eura , M. , Kameyama , T. and Itoh , K.Detection of MAGE‐4 protein in sera of patients with head and neck squamous cell carcinoma . Int. J. Cancer , 70 , 287 – 290 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 15.Shichijo , S. , Hoshino , T. , Koufuji , K. , Hayashi , A. , Kawamoto , M. , Kikuchi , M. , Higuchi , T. , Ichiki , M. , Oizumi , K. and Itoh , K.Detection of MAGE‐4 protein in sera of lung cancer patients . Jpn. J. Cancer Res. , 88 , 414 – 419 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kawagoe , H. , Yamada , A. , Matsumoto , H. , Ito , M. , Ushijima , K. , Nishida , T. , Yakushiji , M. and Itoh , K.Serum MAGE‐4 protein in ovarian cancer patients . Gynecol. Oncol. , 76 , 336 – 339 ( 2000. ). [DOI] [PubMed] [Google Scholar]
- 17.Tsuzurahara , S. , Sata , M. , Iwamoto , O. , Shichijo , S. , Kojiro , M. , Tanikawa , K. and Itoh , K.Detection of MAGE‐4 protein in the sera of patients with hepatitis‐C virus‐associated hepatocellular carcinoma and liver cirrhosis . Jpn. J. Cancer Res. , 88 , 915 – 918 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Jiang , S. Y. , Shyu , R. Y. , Huang , M. R , Tang , H. S. , Young , T. H. , Roffler , S. R. , Chiou , Y. S. and Yeh , M. Y.Detection of alphafetoprotein‐expressing cells in the blood of patients with hepatoma and hepatitis . Br. J. Cancer , 75 , 928 – 933 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Yamashita , F. , Tanaka , M. , Satomura , S. and Tanikawa , K.Prognostic significance of Lens culinaris agglutinin A‐reactive alpha‐fetoprotein in small hepatocellular carcinoma . Gastroenterology , 111 , 996 – 1001 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 20.Fujiyama , S. , Morishita , T. , Sagara , K. , Sato , T. , Motohara , K. and Matsuda , I.Clinical elevation of plasma abnormal prothrombin (PIVKA‐II) in patients with hepatocellular carcinoma . Hepatogastroenterology , 33 , 201 – 205 ( 1986. ). [PubMed] [Google Scholar]
- 21.Taketa , K. , Endo , Y. , Sekiya , C. , Tanikawa , K. , Koji , T. , Taga , H. , Satomura , S. , Matsuura , S. , Kawai , T. and Hirai , H.A collaborative study for the evaluation of lectin‐reactive alpha‐fetoproteins in early detection of hepatocellular carcinoma . Cancer Res. , 53 , 5419 – 5423 ( 1993. ). [PubMed] [Google Scholar]
- 22.Becker , J. C. , Gillitzer , R. and Brocker , E. B.A number of the melanoma antigen‐encoding gene (MAGE) family is expressed in human skin during wound healing . Int. J. Cancer , 58 , 346 – 348 ( 1994. ). [DOI] [PubMed] [Google Scholar]